View ValuationNovoray 将来の成長Future 基準チェック /56Novorayは、38.3%と28.6%でそれぞれ年率38.3%で利益と収益が成長すると予測される一方、EPSはgrowで38.1%年率。主要情報38.3%収益成長率38.07%EPS成長率Chemicals 収益成長29.3%収益成長率28.6%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日23 Apr 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu Chinaお知らせ • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026お知らせ • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025お知らせ • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu Chinaお知らせ • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.お知らせ • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.お知らせ • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.お知らせ • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu ChinaReported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.業績と収益の成長予測XSSC:688300 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20271,960602N/A565112/31/20261,568439N/A38713/31/20261,171301133233N/A12/31/20251,116293157255N/A9/30/20251,090287167263N/A6/30/20251,036273103200N/A3/31/2025997263191291N/A12/31/2024960251165255N/A9/30/2024895234167248N/A6/30/2024841218164236N/A3/31/2024769197137189N/A12/31/2023712174194247N/A9/30/2023685182139203N/A6/30/2023625169156248N/A3/31/2023630174130277N/A12/31/202266218886241N/A9/30/202265717524213N/A6/30/2022686186-47161N/A3/31/2022663179-64117N/A12/31/2021625173-55153N/A9/30/2021581169-94117N/A6/30/2021522147-42135N/A3/31/2021473130-57104N/A12/31/2020404111-3490N/A9/30/2020367921998N/A6/30/2020341822995N/A3/31/20203217827100N/A12/31/201931575N/A81N/A9/30/201929869N/A97N/A6/30/201929267N/A70N/A3/31/201927760N/A53N/A12/31/201827858N/A56N/A9/30/201826454N/A34N/A6/30/201824950N/A12N/A3/31/201823046N/A9N/A12/31/201721142N/A6N/A9/30/201719341N/A17N/A6/30/201717639N/A27N/A3/31/201716536N/A22N/A12/31/201615433N/A18N/A9/30/201614327N/AN/AN/A6/30/201613220N/A16N/A3/31/201612719N/A12N/A12/31/201512218N/A7N/A9/30/201512119N/A3N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 688300の予測収益成長率 (年間38.3% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 688300の収益 ( 38.3% ) はCN市場 ( 27.5% ) よりも速いペースで成長すると予測されています。高成長収益: 688300の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 688300の収益 ( 28.6% ) CN市場 ( 16.8% ) よりも速いペースで成長すると予測されています。高い収益成長: 688300の収益 ( 28.6% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 688300の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/09 22:30終値2026/07/09 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Novoray Corporation 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Yilin HouChina International Capital Corporation LimitedWei LiuHaitong International Research Limited
お知らせ • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026
Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
お知らせ • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
お知らせ • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025
お知らせ • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
お知らせ • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
お知らせ • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
お知らせ • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
お知らせ • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu China
Reported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.
Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.
Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.